Nurse Practitioner in Oglethorpe, GA Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Mrs. Brenda S Oglesby, NURSE PRACTITIONER Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 110 Chatham St, Oglethorpe, GA 31068 Phone: 478-472-8121 Fax: 478-472-2500 |
Mrs. Karen Patricia Hatten, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 300 Medical Ct, Oglethorpe, GA 31068 Phone: 478-458-9992 Fax: 478-458-9969 |
Kaitlyn Anna Hutto, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 300 Medical Ct, Oglethorpe, GA 31068 Phone: 478-458-9942 Fax: 478-458-9969 |
Stephanie Burris, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 300 Medical Court, Oglethorpe, GA 31068 Phone: 478-458-9942 Fax: 478-458-9969 |
News Archive
A burst of brain energy depends more on a unique molecular cycle than on blood flow variation
A century old mystery is taking place in your head as you read these words. Blood vessels in regions of your brain are widening, bathing cells in an increased blood flow.
Functional MRI technique may help predict risk of long-term post-concussive symptoms
For concussion sufferers, even those who never lost consciousness, physicians may now be able to predict early on who is more likely to continue experiencing symptoms months or years after the head-jarring event, using a new non-invasive magnetic resonance imaging method devised by a consortium of researchers led by UC San Francisco scientists.
Improving U.S. hospitals' efficiency could save at least $4 billion, Thomson Reuters says
U.S. hospitals can improve patient care and save at least $4 billion by being more efficient, according to Thomson Reuters, Reuters reports.
NIH-funded study finds way to reduce transmission of malaria to humans
Spraying malaria-transmitting mosquitoes with a genetically modified fungus can kill the malaria parasite without harming the mosquito, potentially reducing malaria transmission to humans, according to a new study published in the journal Science. Funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was led by Raymond J. St. Leger, Ph.D., of the University of Maryland, College Park.
Evotec grants Jingxin Pharma rights to develop, market EVT 201 insomnia drug candidate in China
Evotec AG today announced that it has entered into a license and collaboration agreement with Zhejiang Jingxin Pharmaceutical Co., Ltd for EVT 201, a novel potential treatment for insomnia. The agreement grants Jingxin Pharma exclusive rights to develop and market the drug candidate in China. In return, Evotec will receive a small upfront payment, together with commercial milestones and significant royalties.
› Verified 3 days ago